HCA Healthcare Inc. (NYSE: HCA) Stock News & Analysis
HCA Healthcare Inc. (NYSE: HCA) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 1 article on HCA since Wednesday, July 15, 2026, most recently "Barclays Downgrades HCA Healthcare (NYSE:HCA), Cuts Price Target to $427 from $496" on Wednesday, July 15, 2026. Coverage to date spans Health Care, tracking HCA's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
HCA Coverage -- 1 Article
Barclays Downgrades HCA Healthcare (NYSE:HCA), Cuts Price Target to $427 from $496
Barclays moved HCA to Equal Weight from Overweight on July 8, slashing its target to $427 from $496 amid policy risk and a trimmed full-year profit forecast.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.